In patients with PRLR-low tumor expression and without an early BC event, pathway analysis of TFs exclusively modulated by PRLR in this group showed that PRLR significantly induced TFs of the Notch and p53 pathways (Figure 4B). Here, PRLR is linked to breast cancer.